A Methodological Quality Assessment of Meta-Analysis Studies in Dance Therapy Using AMSTAR and AMSTAR 2

por Kim, Hye-Ryeon, Choi, Chang-Hwan, Jo, Eunhye
Publicado 2020

Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer

por Kim, Hongsik, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Ha, Sang Yun, Park, Joon Oh, Kim, Seung Tae
Publicado 2022

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

por Kim, Hongsik, Kim, Hana, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae
Publicado 2021

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers

por Kim, Hye Ryeon, Ahn, Soomin, Jo, Hyunji, Kim, Hongsik, Hong, Joohyun, Lee, Jeeyun, Lim, Ho-Yeong, Kang, Won Ki, Kim, Seung Tae
Publicado 2021

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer

por Kim, Hongsik, Kim, Ryul, Kim, Hye Ryeon, Jo, Hyunji, Kim, Hana, Ha, Sang Yun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae
Publicado 2022

A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer

por Kim, Hye Ryeon, Lee, Su Jin, Park, Sehhoon, Jung, Hyun Ae, Lee, Se-Hoon, Jeong, Han-Sin, Chung, Man Ki, Ahn, Myung-Ju
Publicado 2022

Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progres...

por Kim, Hye Ryeon, Jo, Hyunji, Kim, Hongsik, Hong, Joohyun, Park, Sehhoon, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin-Seok, Ahn, Myung-Ju
Publicado 2023

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach

por Kim, Hana, Kim, Hyo Jung, Kim, Hongsik, Kim, Hye Ryeon, Jo, Hyunji, Hong, Joohyun, Kim, Ryul, Kim, Ji-Yeon, Ahn, Jin Seok, Im, Young-Hyuck, Lee, Se Kyung, Kim, Haeyoung, Shin, Soo-Yong, Park, Yeon Hee
Publicado 2021

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors

por Kim, Hye Ryeon, Kang, Jung Hun, Kim, Sung Hyun, Kim, Seung Tae, Kim, Ilhwan, Min, Young Joo, Shin, Seong Hoon, Oh, Sung Yong, Lee, Gyeong-Won, Lee, Ji Hyun, Ji, Jun Ho, Huh, Seok Jae, Lee, Suee
Publicado 2022

Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort

por Jo, Hyunji, Park, Seri, Kim, Hye Ryeon, Kim, Hongsik, Hong, Joohyun, Lee, Jeong Eon, Yu, Jonghan, Chae, Byung Joo, Lee, Se Kyung, Ryu, Jai Min, Oh, Soo-young, Choi, Suk Joo, Kim, Ji-Yeon, Ahn, Jin Seok, Im, Young-Hyuck, Nam, Eun Mi, Nam, Seok Jin, Park, Yeon Hee
Publicado 2022

A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma

por Jo, Hyunji, Hong, Joohyun, Kim, Hongsik, Kim, Hye Ryeon, Kwon, Ghee Young, Kang, Kyung A., Park, Sung Yoon, Kim, Chan Kyo, Park, Byung Kwan, Chung, Jae Hoon, Song, Wan, Kang, Minyong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Park, Se Hoon
Publicado 2022